Literature DB >> 22381618

Regulation of the human catalytic subunit of telomerase (hTERT).

Michael Daniel1, Gregory W Peek, Trygve O Tollefsbol.   

Abstract

Over the past decade, there has been much interest in the regulation of telomerase, the enzyme responsible for maintaining the integrity of chromosomal ends, and its crucial role in cellular immortalization, tumorigenesis, and the progression of cancer. Telomerase activity is characterized by the expression of the telomerase reverse transcriptase (TERT) gene, suggesting that TERT serves as the major limiting agent for telomerase activity. Recent discoveries have led to characterization of various interactants that aid in the regulation of human TERT (hTERT), including numerous transcription factors; further supporting the pivotal role that transcription plays in both the expression and repression of telomerase. Several studies have suggested that epigenetic modulation of the hTERT core promoter region may provide an additional level of regulation. Although these studies have provided essential information on the regulation of hTERT, there has been ambiguity of the role of methylation within the core promoter region and the subsequent binding of various activating and repressive agents. As a result, we found it necessary to consolidate and summarize these recent developments and elucidate these discrepancies. In this review, we focus on the co-regulation of hTERT via transcriptional regulation, the presence or absence of various activators and repressors, as well as the epigenetic pathways of DNA methylation and histone modifications. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381618      PMCID: PMC3312932          DOI: 10.1016/j.gene.2012.01.095

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  196 in total

1.  Gene expression changes in response to E2F1 activation.

Authors:  Jens Stanelle; Thorsten Stiewe; Carmen C Theseling; Martin Peter; Brigitte M Pützer
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

2.  Inhibition of telomerase by G-quartet DNA structures.

Authors:  A M Zahler; J R Williamson; T R Cech; D M Prescott
Journal:  Nature       Date:  1991-04-25       Impact factor: 49.962

3.  Integration of biological networks and gene expression data using Cytoscape.

Authors:  Melissa S Cline; Michael Smoot; Ethan Cerami; Allan Kuchinsky; Nerius Landys; Chris Workman; Rowan Christmas; Iliana Avila-Campilo; Michael Creech; Benjamin Gross; Kristina Hanspers; Ruth Isserlin; Ryan Kelley; Sarah Killcoyne; Samad Lotia; Steven Maere; John Morris; Keiichiro Ono; Vuk Pavlovic; Alexander R Pico; Aditya Vailaya; Peng-Liang Wang; Annette Adler; Bruce R Conklin; Leroy Hood; Martin Kuiper; Chris Sander; Ilya Schmulevich; Benno Schwikowski; Guy J Warner; Trey Ideker; Gary D Bader
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells.

Authors:  Masahiro Takakura; Satoru Kyo; Masaki Inoue; Woodring E Wright; Jerry W Shay
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Reconstitution of human telomerase activity in vitro.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Curr Biol       Date:  1998-01-29       Impact factor: 10.834

7.  Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.

Authors:  Rumi Sasaki; Mako Narisawa-Saito; Takashi Yugawa; Masatoshi Fujita; Hironori Tashiro; Hidetaka Katabuchi; Tohru Kiyono
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

8.  Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.

Authors:  Akiko Kimura; Masahide Ohmichi; Jun Kawagoe; Satoru Kyo; Seiji Mabuchi; Toshifumi Takahashi; Chika Ohshima; Emi Arimoto-Ishida; Yukihiro Nishio; Masaki Inoue; Hirohisa Kurachi; Keiichi Tasaka; Yuji Murata
Journal:  Oncogene       Date:  2004-06-03       Impact factor: 9.867

9.  Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.

Authors:  R T Sitaram; S Degerman; B Ljungberg; E Andersson; Y Oji; H Sugiyama; G Roos; A Li
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

10.  Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.

Authors:  R L Beijersbergen; E M Hijmans; L Zhu; R Bernards
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  105 in total

1.  Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.

Authors:  Lifang Yang; Zhijie Xu; Liyu Liu; Xiangjian Luo; Jingchen Lu; Lunquan Sun; Ya Cao
Journal:  Cancer Biol Ther       Date:  2013-10-21       Impact factor: 4.742

2.  Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia.

Authors:  Enrica Rampazzo; Engin Bojnik; Livio Trentin; Laura Bonaldi; Paola Del Bianco; Federica Frezzato; Andrea Visentin; Monica Facco; Gianpietro Semenzato; Anita De Rossi
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

Review 3.  Epigenetic linkage of aging, cancer and nutrition.

Authors:  Michael Daniel; Trygve O Tollefsbol
Journal:  J Exp Biol       Date:  2015-01-01       Impact factor: 3.312

Review 4.  [Reversal of aging and lifespan elongation. Current biomedical key publications and the implications for geriatrics].

Authors:  L C Bollheimer; D Volkert; T Bertsch; C C Sieber; R Büttner
Journal:  Z Gerontol Geriatr       Date:  2013-08       Impact factor: 1.281

Review 5.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

6.  Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice.

Authors:  Chun Huang; Runqin Li; Yinglin Zhang; Jianping Gong
Journal:  Technol Cancer Res Treat       Date:  2016-07-11

Review 7.  Dietary epigenetics in cancer and aging.

Authors:  Trygve O Tollefsbol
Journal:  Cancer Treat Res       Date:  2014

Review 8.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

9.  TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.

Authors:  Li Liu; Cheng Liu; Omid Fotouhi; Yidong Fan; Kun Wang; Chuanyou Xia; Benkang Shi; Guangyong Zhang; Kexin Wang; Feng Kong; Catharina Larsson; Sanyuan Hu; Dawei Xu
Journal:  Oncologist       Date:  2017-07-28

Review 10.  Genetic susceptibility to triple-negative breast cancer.

Authors:  Kristen N Stevens; Celine M Vachon; Fergus J Couch
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.